▲ 23 r/ModernaStock
Merck, Moderna’s personalized cancer vaccine slows recurrence in phase 3, setting up approval push
Merck & Co. and Moderna's personalized mRNA cancer vaccine has successfully lengthened recurrence-free survival (RFS) when paired with Keytruda for patients with high-risk skin cancer. The phase 3 win sets the partners up to potentially seek accelerated approval.
u/guitarjp — 18 hours ago